尋找研究成果

搜尋概念
已選取的篩選器

出版年份

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016

作者

  • Yung-Ching Liu
2016
2019

Functional neutralization of anti-IFN-γ autoantibody in patients with nontuberculous mycobacteria infection

Krisnawati, D. I., Liu, Y. C., Lee, Y. J., Wang, Y. T., Chen, C. L., Tseng, P. C. & Lin, C. F., 四月 5 2019, 於 : Scientific Reports. 9, 1, p. 5682 5682.

研究成果: 雜誌貢獻文章

開啟存取
4 引文 斯高帕斯(Scopus)

Synergy of β-Lactams with Vancomycin against Methicillin-Resistant Staphylococcus aureus: Correlation of Disk Diffusion and Checkerboard Methods

Sy, C. L., Huang, T. S., Chen, C. S., Chen, Y. S., Tsai, H. C., Wann, S. R., Wu, K. S., Chen, J. K., Lee, S. S. J. & Liu, Y. C., 三月 1 2016, 於 : Journal of Clinical Microbiology. 54, 3, p. 565-568 4 p.

研究成果: 雜誌貢獻文章

10 引文 斯高帕斯(Scopus)
2019

Randomized noninferiority trial of cefoperazone-sulbactam versus cefepime in the treatment of hospital-acquired and healthcare-associated pneumonia

Liu, J. W., Chen, Y. H., Lee, W. S., Lin, J. C., Huang, C. T., Lin, H. H., Liu, Y. C., Chuang, Y. C., Tang, H. J., Chen, Y. S., Ko, W. C., Lu, M. C. & Wangn, F. D., 一月 1 2019, 於 : Antimicrobial Agents and Chemotherapy. 63, 8, e00023-19.

研究成果: 雜誌貢獻文章

開啟存取
2 引文 斯高帕斯(Scopus)
2016
1 引文 斯高帕斯(Scopus)
2020

Reply to Zhou and Wu, "be careful with adverse events caused by cefoperazone-sulbactam"

Liu, J. W., Chen, Y. H., Lee, W. S., Lin, J. C., Huang, C. T., Lin, H. H., Liu, Y. C., Chuang, Y. C., Tang, H. J., Chen, Y. S., Ko, W. C., Lu, M. C. & Wangn, F. D., 一月 27 2020, 於 : Antimicrobial Agents and Chemotherapy. 64, 2, e02028.

研究成果: 雜誌貢獻快報